Reporting of population characteristics | ||
---|---|---|
No information on co-morbidities | 7/15 | [24, 25, 29, 30, 32, 33, 35] |
Incomplete or no data on NYHA Classification | 10/15 | [9, 23, 24, 26, 27, 29, 30, 33, 35–37] |
No data on NYHA Classification | 4/15 | [23, 26, 27, 30] |
Range of NYHA Classification only | 6/15 | [24, 25, 28, 31, 32, 37] |
Information on LVEF | 6/15 | [25, 29, 31, 34, 36, 37] |
Summaries of ACE-I and BB medication treatments | 3/15 | [32, 36, 37] |